ELOTUZUMAB for Disease progression: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where ELOTUZUMAB was used for Disease progression.
Most Reported Side Effects for ELOTUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Plasma cell myeloma | 339 | 9.9% | 122 | 82 |
| Death | 234 | 6.8% | 234 | 10 |
| Malignant neoplasm progression | 227 | 6.6% | 88 | 77 |
| Pneumonia | 209 | 6.1% | 58 | 164 |
| Pyrexia | 183 | 5.3% | 35 | 136 |
| Drug ineffective | 137 | 4.0% | 15 | 26 |
| Neutropenia | 133 | 3.9% | 28 | 69 |
| Anaemia | 119 | 3.5% | 36 | 66 |
| Thrombocytopenia | 107 | 3.1% | 17 | 51 |
| Diarrhoea | 105 | 3.1% | 23 | 47 |
| Fatigue | 95 | 2.8% | 17 | 19 |
| Off label use | 93 | 2.7% | 14 | 26 |
| Sepsis | 86 | 2.5% | 50 | 68 |
| Platelet count decreased | 82 | 2.4% | 20 | 37 |
| Febrile neutropenia | 68 | 2.0% | 21 | 49 |
Other Indications for ELOTUZUMAB
Plasma cell myeloma (2,659)
Product used for unknown indication (703)
Plasma cell myeloma refractory (138)
Bone lesion (9)
Plasma cell myeloma recurrent (9)
Immunosuppressant drug therapy (5)
Other Drugs Used for Disease progression
CAPECITABINE (57)
DEXAMETHASONE (53)
CYCLOPHOSPHAMIDE (52)
RITUXIMAB (52)
IRINOTECAN (50)
CARBOPLATIN (48)
IFOSFAMIDE (44)
CISPLATIN (41)
ETOPOSIDE (39)
PREDNISONE (39)